Cargando…
Pilot study of ziv-aflibercept in myopic choroidal neovascularisation patients
BACKGROUND: Myopic choroidal neovascularization (CNV) is the most common sight-threatening complication associated with high myopia. The present study evaluated the efficacy and safety of the intravitreal injection of ziv-aflibercept in patients with myopic CNV. METHODS: This prospective interventio...
Autores principales: | Nawar, Amin E., Shafik, Heba M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7574189/ https://www.ncbi.nlm.nih.gov/pubmed/33076864 http://dx.doi.org/10.1186/s12886-020-01679-4 |
Ejemplares similares
-
Switching to ziv-aflibercept in resistant diabetic macular edema non responsive to ranibizumab injection
por: Nawar, Amin E., et al.
Publicado: (2022) -
Aflibercept as primary treatment for myopic choroidal neovascularisation: a retrospective study
por: Bruè, C, et al.
Publicado: (2016) -
Ziv-aflibercept in macular disease
por: Mansour, Ahmad M, et al.
Publicado: (2015) -
Myopic choroidal neovascularisation: current concepts and update on clinical management
por: Wong, Tien Y, et al.
Publicado: (2015) -
Intravitreal injection of ziv-aflibercept in the treatment of choroidal and retinal vascular diseases
por: HodjatJalali, Kamran, et al.
Publicado: (2017)